Post-tuberculous lung disease: should we be using Theophylline?

Post tuberculous lung disease (PTBLD) chronic obstructive pulmonary disease (COPD) pulmonary hypertension theophylline tuberculosis (TB)

Journal

Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916

Informations de publication

Date de publication:
Feb 2021
Historique:
entrez: 15 3 2021
pubmed: 16 3 2021
medline: 16 3 2021
Statut: ppublish

Résumé

Tuberculosis affects 10 million people and over 320,000 South Africans every year. A significant proportion of patients treated for tuberculosis develop post-tuberculous lung disease (PTBLD), a disease of chronic respiratory impairment for which there is a lack of affordable treatment options. PTBLD a heterogenous disorder that shares phenotypical features with chronic obstructive lung disease, bronchiectasis, lung fibrosis and destruction as well as pulmonary hypertension. There remains a paucity of proven pharmacotherapy for the management of PTBLD. Theophylline, a widely available and affordable medicine that has largely fell out of favour in high-income settings due to its toxicity and narrow therapeutic index, may be repositioned for the treatment of PTBLD. In this review, we unpack the potential role of theophylline in the management of PTBLD by reviewing the evidence for its bronchodilatory, anti-inflammatory and potential pleotrophic effects.

Identifiants

pubmed: 33717595
doi: 10.21037/jtd-20-1298
pii: jtd-13-02-1230
pmc: PMC7947523
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1230-1238

Informations de copyright

2021 Journal of Thoracic Disease. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-20-1298). The authors have no conflicts of interest to declare.

Références

J Antimicrob Chemother. 1996 Jun;37 Suppl C:133-42
pubmed: 8818854
S Afr Med J. 2018 Jun 26;108(7):12339
pubmed: 30004336
Eur Respir Rev. 2018 Feb 28;27(147):
pubmed: 29491034
Respirology. 2004 Jun;9(2):249-54
pubmed: 15182277
Am J Respir Crit Care Med. 2002 May 15;165(10):1371-6
pubmed: 12016098
J Allergy Clin Immunol. 1999 Jul;104(1):14-21
pubmed: 10400833
Pulm Pharmacol Ther. 2007;20(1):46-51
pubmed: 16413994
Clin Pharmacol Ther. 2012 Oct;92(4):414-7
pubmed: 22992668
Thorax. 2006 Sep;61(9):761-6
pubmed: 16936236
Respir Med. 2005 Feb;99(2):135-44
pubmed: 15715180
JAMA. 2018 Oct 16;320(15):1548-1559
pubmed: 30326124
N Engl J Med. 1989 Jun 8;320(23):1521-5
pubmed: 2498658
Clin Pharmacol Ther. 2003 May;73(5):468-74
pubmed: 12732846
Ann Allergy Asthma Immunol. 1996 Jul;77(1):34-8
pubmed: 8705632
J Thorac Dis. 2018 Oct;10(Suppl 28):S3428-S3435
pubmed: 30505530
Eur J Clin Pharmacol. 2006 Aug;62(8):627-31
pubmed: 16841220
Chest. 1987 Jul;92(1 Suppl):27S-31S
pubmed: 3297524
Chest. 2010 Jun;137(6):1338-44
pubmed: 20299628
Int J Chron Obstruct Pulmon Dis. 2012;7:245-52
pubmed: 22563244
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8921-6
pubmed: 12070353
Respirology. 2006 Sep;11(5):603-10
pubmed: 16916334
Chest. 1981 Dec;80(6 Suppl):889-92
pubmed: 7030662
BMB Rep. 2010 Aug;43(8):530-4
pubmed: 20797314
Allergy. 2001 Nov;56(11):1087-90
pubmed: 11703224
Int J Pharm Investig. 2017 Jul-Sep;7(3):119-124
pubmed: 29184823
Lancet. 1994 Apr 23;343(8904):1006-8
pubmed: 7909049
J Exp Med. 2004 Sep 6;200(5):689-95
pubmed: 15337792
Eur Respir J. 2007 Nov;30(5):865-77
pubmed: 17626110
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545968
Am J Respir Cell Mol Biol. 2016 Jun;54(6):792-801
pubmed: 26574643
Trends Pharmacol Sci. 2009 Oct;30(10):528-35
pubmed: 19762093
Eur Respir J. 2003 May;21(5):892-905
pubmed: 12765440
Am J Respir Crit Care Med. 2013 Oct 15;188(8):901-6
pubmed: 23672674
Pulm Pharmacol Ther. 2008 Dec;21(6):874-8
pubmed: 18983928
Biochem Pharmacol. 1995 Jul 17;50(2):205-11
pubmed: 7632164
S Afr Med J. 2013 May;103(5):298-303
pubmed: 23971118
Cell Immunol. 2000 Aug 1;203(2):95-102
pubmed: 11006007
Cochrane Database Syst Rev. 2001;(1):CD002734
pubmed: 11279764
Am J Respir Crit Care Med. 2001 Jul 15;164(2):273-6
pubmed: 11463600
Thorax. 2009 May;64(5):424-9
pubmed: 19158122
Chest. 1985 Aug;88(2 Suppl):112S-117S
pubmed: 3893923
Allergy. 2016 Apr;71(4):571-5
pubmed: 26715426
Eur Respir J. 1995 Apr;8(4):637-42
pubmed: 7664866
Chest. 2001 Jun;119(6):1661-70
pubmed: 11399688
Chest. 2016 Jul;150(1):123-30
pubmed: 27107490

Auteurs

Sumanth Karamchand (S)

Division of Pulmonology, Western Cape Department of Health, Tygerberg Hospital, Bellville, South Africa.

Morne Williams (M)

Division of Pulmonology, Western Cape Department of Health, Tygerberg Hospital, Bellville, South Africa.

Poobalan Naidoo (P)

Department of Informatics, School of Health Professions, Rutgers University, New Jersey, USA.

Eric Decloedt (E)

Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Bellville, South Africa.

Brian Allwood (B)

Division of Pulmonology, Western Cape Department of Health, Tygerberg Hospital, Bellville, South Africa.

Classifications MeSH